These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3464085)

  • 1. Cytogenetic analysis in 941 consecutive patients with haematologic disorders.
    Billström R; Nilsson PG; Mitelman F
    Scand J Haematol; 1986 Jul; 37(1):29-40. PubMed ID: 3464085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic patterns in 384 northern-Spanish patients with haematological disorders.
    Cigudosa JC; Calasanz MJ; García Delgado M; Gullón A
    Hereditas; 1993; 118(1):79-85. PubMed ID: 8478209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of a hematologic cytogenetic laboratory to the diagnosis, classification and prognosis of various hematologic malignancies].
    Debray J; Krulik M; Smadja NV
    Bull Acad Natl Med; 1992 May; 176(5):629-38; discussion 638-40. PubMed ID: 1422868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytogenetic studies in hematological diseases. Analysis of 185 cases].
    Porto B; Mota A; Coutinho J; Justiça B; Malheiro MI
    Sangre (Barc); 1993 Apr; 38(2):103-14. PubMed ID: 8516724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders.
    Pollak C; Hagemeijer A
    Leukemia; 1987 Jul; 1(7):541-8. PubMed ID: 3312844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
    Johansson B; Mertens F; Mitelman F
    Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of chromosome studies in cancer.
    Nowell PC
    Ann Clin Lab Sci; 1974; 4(4):234-40. PubMed ID: 4533399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome abnormalities in malignant hematologic disorders.
    Dewald GW; Noel P; Dahl RJ; Spurbeck JL
    Mayo Clin Proc; 1985 Oct; 60(10):675-89. PubMed ID: 3897733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of chromosome arm 3p in hematologic malignancies.
    Johansson B; Billström R; Kristoffersson U; Akerman M; Garwicz S; Ahlgren T; Malm C; Mitelman F
    Leukemia; 1997 Aug; 11(8):1207-13. PubMed ID: 9264371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients.
    Pedersen-Bjergaard J; Philip P; Pedersen NT; Hou-Jensen K; Svejgaard A; Jensen G; Nissen NI
    Cancer; 1984 Aug; 54(3):452-62. PubMed ID: 6733676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients.
    Olesen LH; Clausen N; Dimitrijevic A; Kerndrup G; Kjeldsen E; Hokland P
    Br J Haematol; 2004 Oct; 127(1):59-66. PubMed ID: 15384978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myeloid disorders: background.
    Swansbury J
    Methods Mol Biol; 2003; 220():23-42. PubMed ID: 12744204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White cells 2: impact of understanding the molecular basis of haematological malignant disorders on clinical practice.
    Stewart AK; Schuh AC
    Lancet; 2000 Apr; 355(9213):1447-53. PubMed ID: 10791539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic studies in chronic granulocytic leukaemia.
    Dougan L; Onesti P; Woodliff HJ
    Australas Ann Med; 1967 Feb; 16(1):52-61. PubMed ID: 5230982
    [No Abstract]   [Full Text] [Related]  

  • 17. General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997.
    Secker-Walker LM
    Leukemia; 1998 May; 12(5):776-8. PubMed ID: 9593280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of cytogenetics in neoplastic diseases.
    Sandberg AA
    Crit Rev Clin Lab Sci; 1985; 22(3):219-74. PubMed ID: 3899509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic studies in chronic myeloproliferative disorders.
    Carbonell F; Ganser A; Heimpel H
    Acta Haematol; 1983; 69(3):145-51. PubMed ID: 6404096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome changes in cancer.
    Mitelman F
    Cancer Detect Prev; 1986; 9(1-2):31-40. PubMed ID: 3460701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.